Lonvi Biosciences, a company based in Shenzhen, China, is working on a new biotechnological drug that offers the possibility of extending human life up to 120 years. This was reported by Zamin.uz.
The New York Times reported on this. According to experts, the main ingredient of this preparation is a natural extract derived from grape seeds.
This compound can eliminate “senescent” cells that appear during the aging process in the body and restore the function of healthy cells. As a result, not only lifespan but also its quality and activity increase.
It is known that grape seeds have long been famous in traditional Chinese medicine and Western dietary science for their properties to preserve youth and improve blood circulation. Scientists at Lonvi Biosciences have developed a technology to convert this natural substance into highly concentrated molecules.
The company has now begun clinical trials of the drug. According to them, if these capsules are used together with a healthy lifestyle, proper nutrition, and regular medical supervision, they may help extend human life to 100–120 years.
Experts emphasize that this approach could change traditional concepts of aging and initiate a new era in biotechnology. This innovation could be an important step in improving both the quality and longevity of life.
